Impact of the SGLT2 inhibitor empagliflozin on urinary supersaturations in kidney stone formers (SWEETSTONE trial): protocol for a randomised, double-blind, placebo-controlled cross-over trial - Concepedia

Concepedia

Publication | Open Access

Impact of the SGLT2 inhibitor empagliflozin on urinary supersaturations in kidney stone formers (SWEETSTONE trial): protocol for a randomised, double-blind, placebo-controlled cross-over trial

DOI Full Paper Access

29

Citations

40

References

2022

Year

Simeon Schietzel, Lia Bally, Grazia M. Cereghetti, Nicolas Faller, Matthias B. Moor, Bruno Vogt, Felix Rintelen, Sven Trelle, Daniel G. Fuster

Abstract

NCT04911660; Pre-results.

References

	Year	Citations

Page 1